Roger D. Kitterman

Mi3 Venture Partners Management LLC (MI3 Venture Partners) is a venture capital firm founded in 1999 by William D. McPhee. The firm is headquartered in Wellesley, Massachusetts.

A subsidiary of Lee Munder Capital Group LP, Lee Munder Venture Partners LLC (LMVP) is based in Boston. They also maintain offices in Palm Beach, Florida and New York State. The firm is not associated with Munder Capital Management or its affiliates. They were founded in 2000.

Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts.

TargAnox, Inc. develops therapeutics to prevent oxidative stress diseases. Its products are used for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins. The company was founded by Joseph Loscalzo and L. Gordon Letts in 2008 and is headquartered in New York, NY.

Bezoloven, Inc. had developed pediatric therapeutic services. The firm sponsored a clinical trial of a poisoning treatment for children. The company was founded by Roger David Kitterman in 2007 and was headquartered in Brookline, MA.

Daktari Diagnostics, Inc. operates as a holding company that provides healthcare solutions. The firm engages in the development of point-of-care diagnostic systems for global health applications. Its product includes Daktari Virology which detects HIV and HCV, Daktari InSight which provides data management services, and Daktari Sickle Cell which detects sickle cell disease on infants. The company was founded by William Rodriguez in 2008 and is headquartered in Cambridge, MA.

VisionScope Technologies LLC provides minimally invasive, arthroscopic imaging technology that allows physician to clearly view and evaluate joint condition. It offers sterile procedure kits, needle endoscope, camera head, and camera control unit. The company was founded by Thomas J. Gill IV and Kevin Sibley on August 9, 2007 and is headquartered in Littleton, MA.

CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA.

Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA.